Published in EBioMedicine on September 30, 2016
ω-3 and ω-6 long-chain PUFAs and their enzymatic metabolites in neovascular eye diseases. Am J Clin Nutr (2017) 0.75
Therapeutic Effects of PPARα Agonist on Ocular Neovascularization in Models Recapitulating Neovascular Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci (2017) 0.75
Adiponectin Mediates Dietary Omega-3 Long-Chain Polyunsaturated Fatty Acid Protection Against Choroidal Neovascularization in Mice. Invest Ophthalmol Vis Sci (2017) 0.75
Dose translation from animal to human studies revisited. FASEB J (2007) 15.67
Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet (2005) 13.18
Effects of medical therapies on retinopathy progression in type 2 diabetes. N Engl J Med (2010) 10.75
Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci (1994) 10.46
Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial. Lancet (2007) 6.82
Diabetic retinopathy. N Engl J Med (2012) 5.79
Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants. Pharmacogenetics (2004) 5.12
Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis. Nat Med (2007) 4.36
PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene. EMBO J (1996) 4.11
Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis. Nat Protoc (2009) 3.31
The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina. Prog Retin Eye Res (2005) 3.03
The mouse retina as an angiogenesis model. Invest Ophthalmol Vis Sci (2010) 2.61
Use of the mouse aortic ring assay to study angiogenesis. Nat Protoc (2011) 2.42
PPARalpha activators inhibit cytokine-induced vascular cell adhesion molecule-1 expression in human endothelial cells. Circulation (1999) 2.02
Retinopathy of prematurity. Lancet (2013) 1.82
11,12-Epoxyeicosatrienoic acid-induced inhibition of FOXO factors promotes endothelial proliferation by down-regulating p27Kip1. J Biol Chem (2003) 1.78
Serum concentrations of bevacizumab (avastin) and vascular endothelial growth factor in infants with retinopathy of prematurity. Am J Ophthalmol (2011) 1.69
Epoxy metabolites of docosahexaenoic acid (DHA) inhibit angiogenesis, tumor growth, and metastasis. Proc Natl Acad Sci U S A (2013) 1.66
5-Lipoxygenase metabolite 4-HDHA is a mediator of the antiangiogenic effect of ω-3 polyunsaturated fatty acids. Sci Transl Med (2011) 1.63
Computer-aided quantification of retinal neovascularization. Angiogenesis (2009) 1.50
Reliability of the mouse model of choroidal neovascularization induced by laser photocoagulation. Invest Ophthalmol Vis Sci (2014) 1.49
Anti-vascular endothelial growth factor treatment for eye diseases. BMJ (2012) 1.48
Epoxyeicosatrienoic acids enhance embryonic haematopoiesis and adult marrow engraftment. Nature (2015) 1.47
Rationale, design, and methods of the Action to Control Cardiovascular Risk in Diabetes Eye Study (ACCORD-EYE). Am J Cardiol (2007) 1.47
{omega}-3 Long-chain polyunsaturated fatty acid intake and 12-y incidence of neovascular age-related macular degeneration and central geographic atrophy: AREDS report 30, a prospective cohort study from the Age-Related Eye Disease Study. Am J Clin Nutr (2009) 1.44
Endothelial expression of human cytochrome P450 epoxygenase CYP2C8 increases susceptibility to ischemia-reperfusion injury in isolated mouse heart. FASEB J (2011) 1.33
Fenofibrate - a potential systemic treatment for diabetic retinopathy? Am J Ophthalmol (2012) 1.31
Fenofibrate regulates retinal endothelial cell survival through the AMPK signal transduction pathway. Exp Eye Res (2007) 1.22
Eicosapentaenoic acid is anti-inflammatory in preventing choroidal neovascularization in mice. Invest Ophthalmol Vis Sci (2007) 1.17
A peroxisome proliferator-activated receptor-alpha activator induces renal CYP2C23 activity and protects from angiotensin II-induced renal injury. Am J Pathol (2004) 1.15
Examination of 209 drugs for inhibition of cytochrome P450 2C8. J Clin Pharmacol (2005) 1.15
Fenofibrate activates AMPK and increases eNOS phosphorylation in HUVEC. Biochem Biophys Res Commun (2006) 1.13
Fenofibrate inhibits angiogenesis in vitro and in vivo. Cell Mol Life Sci (2003) 1.12
Pathogenic role of diabetes-induced PPAR-α down-regulation in microvascular dysfunction. Proc Natl Acad Sci U S A (2013) 1.07
Modulation of angiogenesis by omega-3 polyunsaturated fatty acids is mediated by cyclooxygenases. Blood (2008) 1.03
Identification and localization of five CYP2Cs in murine extrahepatic tissues and their metabolism of arachidonic acid to regio- and stereoselective products. J Pharmacol Exp Ther (2001) 1.01
Optimization of an Image-Guided Laser-Induced Choroidal Neovascularization Model in Mice. PLoS One (2015) 0.90
Protective and antioxidant effects of PPARα in the ischemic retina. Invest Ophthalmol Vis Sci (2014) 0.88
Spry1 and Spry4 differentially regulate human aortic smooth muscle cell phenotype via Akt/FoxO/myocardin signaling. PLoS One (2013) 0.88
Cytochrome P450 2C8 ω3-long-chain polyunsaturated fatty acid metabolites increase mouse retinal pathologic neovascularization--brief report. Arterioscler Thromb Vasc Biol (2014) 0.88
Sprouty4 regulates endothelial cell migration via modulating integrin β3 stability through c-Src. Angiogenesis (2013) 0.87
Choroid sprouting assay: an ex vivo model of microvascular angiogenesis. PLoS One (2013) 0.87
Variation in lipid-associated genes as they relate to risk of advanced age-related macular degeneration. World Rev Nutr Diet (2009) 0.86
Modified Lipoproteins in Diabetic Retinopathy: A Local Action in the Retina. J Clin Exp Ophthalmol (2013) 0.86
Soluble epoxide hydrolase disruption as therapeutic target for wound healing. J Surg Res (2012) 0.84
Omega-3 polyunsaturated fatty acids preserve retinal function in type 2 diabetic mice. Nutr Diabetes (2012) 0.84
Endothelial microRNA-150 is an intrinsic suppressor of pathologic ocular neovascularization. Proc Natl Acad Sci U S A (2015) 0.83
Cytochrome P450-generated metabolites derived from ω-3 fatty acids attenuate neovascularization. Proc Natl Acad Sci U S A (2014) 0.83
PPARα regulates mobilization and homing of endothelial progenitor cells through the HIF-1α/SDF-1 pathway. Invest Ophthalmol Vis Sci (2014) 0.82
Diabetic retinopathy and age-related macular degeneration in the U.S. Am J Prev Med (2012) 0.81
Deficiency of Sef is associated with increased postnatal cortical bone mass by regulating Runx2 activity. J Bone Miner Res (2014) 0.81
Lipid metabolites in the pathogenesis and treatment of neovascular eye disease. Br J Ophthalmol (2011) 0.81
Neuroprotective response after photodynamic therapy: role of vascular endothelial growth factor. J Neuroinflammation (2011) 0.80
Is fenofibrate a reasonable treatment for diabetic microvascular disease? Curr Diab Rep (2015) 0.79
Spry1 is expressed in hemangioblasts and negatively regulates primitive hematopoiesis and endothelial cell function. PLoS One (2011) 0.79
Effect of fenofibrate on retinal neurodegeneration in an experimental model of type 2 diabetes. Acta Diabetol (2014) 0.79
Effects of Docosahexaenoic Acid in Preventing Experimental Choroidal Neovascularization in Rodents. J Clin Exp Ophthalmol (2011) 0.79
Sef Regulates Epithelial-Mesenchymal Transition in Breast Cancer Cells. J Cell Biochem (2016) 0.78
Review: adiponectin in retinopathy. Biochim Biophys Acta (2016) 0.78
Cytochrome P450 Oxidase 2C Inhibition Adds to ω-3 Long-Chain Polyunsaturated Fatty Acids Protection Against Retinal and Choroidal Neovascularization. Arterioscler Thromb Vasc Biol (2016) 0.78
Effects of fenofibric acid on diabetic macular edema: the MacuFen study. Ophthalmic Epidemiol (2014) 0.77